SCHEMBL8218208

SCHEMBL8218208

COc1ccc(-c2nn(C)nc2-c2ccccc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.61
▸ ALDH1A1 P00352 3/20 0.61
▸ L3MBTL1 Q9Y468 3/20 0.61
▸ LMNA P02545 1/20 0.61
▸ NPSR1 Q6W5P4 1/20 0.61
▸ TDP1 Q9NUW8 1/20 0.61
▸ RAB9A P51151 4/20 0.53
▸ NPC1 O15118 3/20 0.53
▸ MEN1 O00255 3/20 0.53
▸ KMT2A Q03164 3/20 0.53
▸ MAPT P10636 2/20 0.53
▸ SMN1; SMN2 Q16637 2/20 0.53
▸ TP53 P04637 1/20 0.51
▸ ADORA1 P30542 2/20 0.49
▸ ADORA2A P29274 2/20 0.49
▸ HTT P42858 1/20 0.49
▸ NLRP3 Q96P20 1/20 0.49
▸ ATM Q13315 1/20 0.49
▸ CCNA2 P20248 1/20 0.48
▸ CDK2 P24941 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8214146 0.85 NUDT14 (0.50) KDM4EALDH1A1L3MBTL1LMNANPSR1
SCHEMBL8205966 0.84 KMT2A (0.48) KDM4EALDH1A1L3MBTL1NPSR1TDP1
SCHEMBL3277198 0.84 KDM4E (0.51) KDM4EL3MBTL1RAB9ANPC1MEN1
SCHEMBL14298815 0.84 MEN1 (0.45) KDM4EALDH1A1L3MBTL1LMNANPSR1
SCHEMBL8213977 0.82 LMNA (0.51) KDM4EALDH1A1L3MBTL1LMNANPSR1
SCHEMBL13510724 0.82 KDM4E (0.57) KDM4EALDH1A1L3MBTL1LMNANPSR1
SCHEMBL13509150 0.81 KDM4E (0.56) KDM4EALDH1A1L3MBTL1LMNANPSR1
SCHEMBL8219599 0.80 FLT3 (0.49) KDM4EALDH1A1L3MBTL1LMNANPSR1
SCHEMBL8207607 0.79 PDE10A (0.54) KDM4EALDH1A1L3MBTL1LMNATDP1
SCHEMBL8215862 0.78 KDR (0.48) KDM4ELMNANPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008021960-A2 TRIAZOLYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2008-02-21 — — WO disclosed
Send feedback